CSHL and Hofstra Northwell Health Clinical and Translational Fellowship

Medical Oncology/Hematology Fellowship Program – Translational Research Training Track

In conjunction with Hofstra Northwell Health School of Medicine and the North Shore Hospital and Long Island Jewish Medical Center Division of Medical Oncology, Cold Spring Harbor Laboratory will be participating in the newly created, ACGME-accredited Translational Research Training track of the Medical Oncology/Hematology Fellowship Program. The goal of this translational research-focused fellowship training program is to foster the development of academic medical oncologists who will focus on future research and innovation towards prevention, improved treatments, and ultimately the cure of cancer.

This training program will consist of 14 months of clinical training at Northwell Health hospitals and ambulatory cancer center in Lake Success, NY, followed by two years of post-doctoral translational research training at Cold Spring Harbor Laboratory. After successful completion, fellows will be eligible to take the medical oncology examination administered by the American Board of Internal Medicine.

For more detailed information, including candidate requirements, training outlines and more, please visit the fellowship site.

Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. The CSHL Cancer Center is a basic research facility committed to exploring the fundamental biology of human cancer. The research covers a broad range of cancer types, including breast, prostate, leukemia, glioma, pancreatic, sarcoma, lung and melanoma. Three Scientific Programs provide focus in Gene Regulation & Cell Proliferation, Signal Transduction, and Cancer Genetics. The Cancer Center currently has approximately 37 faculty members. More information about CSHL cancer research and faculty is available through the Cancer Center.

The Hofstra Northwell Health School of Medicine Medical Oncology/Hematology Fellowship Program located in Lake Success, New York, has an over 30 year history of developing leaders in medical oncology and hematology. Our program is approved by the American Board of Internal Medicine (ABIM) and the Accreditation Council for Graduate Medical Education (ACGME). The Fellowship Program offers a comprehensive curriculum for the evaluation, treatment and both clinical and translational research of blood disorders and cancer. The broad spectrum of oncologic and hematologic diseases and the diversity of patients at our tertiary hospitals (the North Shore University Hospital and the Long Island Jewish Medical Center) allow for a robust training experience.

  • Fellows will complete clinical requirements through inpatient rotations, outpatient rotations, and continuity clinic. For more information on clinical requirements, please visit the Northwell Health website.
  • During the remaining two years, fellows will implement and complete a research project under the guidance of a CSHL faculty mentor. Fellows will become skilled in research ethics, regulatory knowledge, biostatistics, research methodology and data computerization. In addition, the fellow will be exposed to various research seminars, research activities, and career development activities. To learn more about research at the Lab, view CSHL faculty profiles.
  • Fellows will have a basic translational research mentor from CSHL as well as a clinical translational mentor from Northwell Health Cancer Institute to guide the development of their clinical research training throughout this fellowship program.

Applications for our Medical Oncology/Hematology Fellowship Program should be submitted through the Electronic Residency Application System (ERAS). Upon applying, candidates should choose the Medical Oncology/Hematology Track or the Translational Research Track. If selected, candidates will be invited to interview and tour CSHL and Northwell Health facilities.

Interested candidates are encouraged to send their CV to the Program Coordinator Kerry Wallace prior to submitting the ERAS application.

Applications are due August 15th.

See the FAQ for more information.

photo of Mali Barbi, CSHL and Hofstra Northwell Health Clinical and Translational Fellow

Mali Barbi, M.D. – Beyaz Lab

As a translational hematology/oncology fellow at Northwell in collaboration with CSHL, my passion lies in becoming an oncologist physician-scientist, dedicated to bridging the knowledge gained from laboratory findings to improve patient care. My goal is to lead clinical translational trials for innovative therapies and develop risk stratification tools.

My academic journey began with a Bachelor of Science in neuroscience, followed by a master’s degree at Tel-Aviv University. During this time, I conducted research in the lab of Prof. Oran Elroy Stein, focusing on neuroimmunology. This work revealed the critical role played by microglial cell activation in mediating pathophysiological processes, igniting my passion for the intersection of research and clinical practice.

Subsequently, I pursued medical school at The Faculty of Medicine at Tel Aviv University and completed my clinical training in internal medicine at Montefiore Medical Center, Bronx, NY. Throughout residency, my commitment to research persisted, encompassing both basic science and clinical research. At Albert Einstein University, I served as a clinical fellow in Dr. Xingxing Zang’s lab, concentrating on the production and characterization of potential novel immunomodulator antibodies.

My dedication to addressing unmet needs in gynecologic oncology through translational and clinical trials led me to the Beyaz Lab at Cold Spring Harbor Laboratory. Here, the unique translational approach of Bedside-to-Bench-to-Bedside, with a focus on endometrial and colorectal cancers, captivated me. Utilizing patient-derived endometrial cancer organoids, the lab aims to decipher the tumor microenvironment and translate research findings into clinical applications.

In the Beyaz Lab, my primary research project involves modeling human endometrial cancer with autologous patient-derived organoids and immune cells for therapeutic discovery. This work represents a crucial step in understanding the intricate immune-tumor crosstalk. My dual engagement in basic science and clinical work gives me the advantage of identifying novel targets and immunomodulators for cancer therapeutics.

Jung-In Yang, MD – Fearon Lab

Takeo Fuji, MD – Egeblad Lab

David Chitty, MD – Lee Lab